Identification and validation of PANoptosis-related biomarkers in Alzheimer’s disease via single-cell RNA sequencing and machine learning
Authors:
Open Access
- 25 November 2025
- journal article
- research article
- Published by Springer Nature in European Journal of Medical Research
- Vol. 30 (1) , 1170
Abstract
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder with complex underlying mechanisms. PANoptosis, a newly defined form of programmKeywords
Funding Information
- Henan Academy of Medical Sciences (QNYJ2023001)
This publication has 53 references indexed in Scilit:
- NLRP3-Mediated PANoptosis and Associated Interventions in Endothelial InjuryCardiovascular Toxicology, 2025
- Analysis of the splicing landscape of the frontal cortex in FTLD-TDP reveals subtype specific patterns and cryptic splicingActa Neuropathologica, 2025
- Revolutionizing Alzheimer’s Detection: Immune-Related Gene Biomarkers as Non-Invasive PredictorsMolecular Neurobiology, 2025
- The Interplay Between Accumulation of Amyloid-Beta and Tau Proteins, PANoptosis, and Inflammation in Alzheimer’s DiseaseNeuroMolecular Medicine, 2024
- The Role of Non-Coding RNAs in Mitochondrial Dysfunction of Alzheimer’s DiseaseJournal of Molecular Neuroscience, 2024
- 2024 Alzheimer's disease facts and figuresAlzheimer's & Dementia, 2024
- Regulated cell death and its role in Alzheimer’s disease and amyotrophic lateral sclerosisActa Neuropathologica, 2024
- Bach2 regulates B cell survival to maintain germinal centers and promote B cell memoryBiochemical and Biophysical Research Communications, 2022
- Mechanisms of NLRP3 Inflammasome Activation: Its Role in the Treatment of Alzheimer’s DiseaseNeurochemical Research, 2020
- GGNBP2 acts as a tumor suppressor by inhibiting estrogen receptor α activity in breast cancer cellsBreast Cancer Research and Treatment, 2016